Alcohol and Rheumatoid Arthritis: Weighing Risks Versus Benefits

The Complex Relationship

Epidemiologic studies show a J-shaped curve: light-to-moderate drinking correlates with lower RA risk and possibly milder disease, but heavier use increases inflammation, medication toxicity, and comorbidity burden.

Potential Benefits (Light-Moderate Intake)

• Some cohorts: 1–3 drinks/week associated with 20–30% lower RA incidence.
• Alcohol may modestly raise HDL and reduce CRP in non-RA populations.
• Psychosocial relaxation may temporarily lower perceived pain.

Documented Risks

• Methotrexate + Alcohol: Synergistic hepatotoxicity → fibrosis/cirrhosis. Guidelines vary: ≤14 units/week (UK) or avoid entirely (some US providers).
• Leflunomide: Also hepatotoxic; alcohol amplifies risk.
• NSAIDs + Alcohol: GI bleed and ulcer risk multiplies.
• Biologics/JAK inhibitors: Alcohol may worsen infection susceptibility.
• Gout Flares: Beer and high-purine spirits trigger attacks in comorbid gout.
• Sleep Disruption: Fragmented sleep → next-day fatigue and pain amplification.
• Weight Gain: Empty calories → obesity → higher inflammatory load.

Practical Recommendations

1. Abstain if: Active hepatitis, cirrhosis, uncontrolled RA, pregnancy, history of alcohol use disorder, or on high-dose methotrexate/leflunomide per physician advice.
2. If drinking, limit to: ≤1 standard drink/day (women), ≤2 (men). One drink = 12 oz beer, 5 oz wine, 1.5 oz spirits.
3. Separate from medications: Take methotrexate on a non-drinking day; allow 24–48 hour gap.
4. Hydrate: Alternate alcoholic drinks with water.
5. Monitor: LFTs every 8–12 weeks on hepatotoxic DMARDs; report increased joint pain after drinking.

Bottom Line

For most RA patients, the safest approach is minimal or no alcohol. Any consumption should be individualized with your rheumatology team.